Finance

Lists
OGN:NYSE
Organon & Co
13,75 $
-0,29%
(-0,040) 1D
13,76 $
+0,07% (+0,010)
Pre-market
Closed: 8 հոկ, 16:00:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OGN...
Open
13,78 $
High
13,80 $
Low
13,75 $
Mkt. cap
3,61 մլրդ
Avg. vol.
2,66 մլն
Volume
1,40 հզր
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,61
52-wk high
13,80 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
Open
13,78 $
High
13,80 $
Low
13,75 $
Mkt. cap
3,61 մլրդ
Avg. vol.
2,66 մլն
Volume
1,40 հզր
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,61
52-wk high
13,80 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 հզր
Founded1923
HeadquartersՋերսի Սիթի, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Navann Ty
Exane BNP Paribas
Hold
Downgraded
14,00 $
+1,8%
04/28/2026
David Amsellem
Piper Sandler
Hold
Upgraded
14,00 $
+1,8%
04/28/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/10/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
9,00 $
-34,5%
04/10/2026
Glen Santangelo
Barclays
Sell
Maintained
8,00 $
-41,8%
02/24/2026
Chris Schott
J.P. Morgan
Sell
Maintained
11,00 $
-20%
02/13/2026
Jason Gerberry
Bank of America Securities
Sell
Maintained
-
-
02/13/2026
Last report
31 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,85 $ / 1,07 $
-20,56%miss
Revenue / Est. (USD)
1,56 մլրդ / 1,56 մլրդ
+0,12%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,60 մլրդ
1,51 մլրդ
1,46 մլրդ
1,56 մլրդ
Cost of goods sold
733,00 մլն
741,00 մլն
670,00 մլն
711,00 մլն
Cost of revenue
733,00 մլն
741,00 մլն
670,00 մլն
711,00 մլն
Research and development expenses
84,00 մլն
91,00 մլն
93,00 մլն
90,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415,00 մլն
431,00 մլն
424,00 մլն
434,00 մլն
Operating expense
499,00 մլն
522,00 մլն
517,00 մլն
524,00 մլն
Total operating expenses
1,23 մլրդ
1,26 մլրդ
1,19 մլրդ
1,24 մլրդ
Operating income
370,00 մլն
244,00 մլն
273,00 մլն
323,00 մլն
Other non operating income
30,00 մլն
-18,00 մլն
15,00 մլն
-3,00 մլն
EBT including unusual items
243,00 մլն
-148,00 մլն
213,00 մլն
183,00 մլն
EBT excluding unusual items
255,00 մլն
103,00 մլն
170,00 մլն
210,00 մլն
Income tax expense
83,00 մլն
57,00 մլն
67,00 մլն
75,00 մլն
Effective tax rate
34,16%
-38,51%
31,46%
40,98%
Other operating expenses
-
-
-
-
Net income
160,00 մլն
-205,00 մլն
146,00 մլն
108,00 մլն
Net profit margin
9,99%
-13,60%
10,00%
6,93%
Earnings per share
1,01
0,63
0,71
0,85
Interest and investment income
-
-
-
-
Interest expense
-128,00 մլն
-121,00 մլն
-111,00 մլն
-108,00 մլն
Net interest expenses
-128,00 մլն
-121,00 մլն
-111,00 մլն
-108,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
462,00 մլն
340,00 մլն
359,00 մլն
403,00 մլն
Gain or loss from assets sale
-
-
-81,00 մլն
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps